Breast Cancer Trial, Recruiting (NCT06728527)

Breast Cancer Trial, Recruiting NCT06728527 Sponsor: Cambridge University Hospitals NHS Foundation Trust Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06728527 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People having a partial breast reconstruction using a specific technique called a chest wall perforator flap (CWPF) for primary breast cancer
People having a procedure to correct breast shape changes that occurred after a previous breast-conserving surgery
The surgery must be performed by a surgeon who has already carried out at least 10 of these CWPF procedures
The hospital or clinic taking part must expect to complete at least 10 of these procedures per year

Who may not be able to join:

People having a type of breast-conserving surgery where tissue is moved within the breast to fill a gap (called volume displacement surgery)
People having a full breast removal (mastectomy), with or without immediate breast reconstruction

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amit Agrawal, Cambridge University Hospitals NHS Foundation Trust

Phone: +44 1223 216315

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06728527

Sponsor: Cambridge University Hospitals NHS Foundation Trust

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: +44 1223 216315

More information: https://clinicaltrials.gov/study/NCT06728527

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People having a partial breast reconstruction using a specific technique called a chest wall perforator flap (CWPF) for primary breast cancer
People having a procedure to correct breast shape changes that occurred after a previous breast-conserving surgery
The surgery must be performed by a surgeon who has already carried out at least 10 of these CWPF procedures
The hospital or clinic taking part must expect to complete at least 10 of these procedures per year

Who may not be able to join:

People having a type of breast-conserving surgery where tissue is moved within the breast to fill a gap (called volume displacement surgery)
People having a full breast removal (mastectomy), with or without immediate breast reconstruction

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Registry

ClinicalTrials.gov

Start date

1 June 2023

Est. completion

31 May 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Surgical Complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov